REGENERON PHARMACEUTICALS, INC.
Pharmaceutical Preparations | SIC: 2834Phone: 9148477000
EIN: 133444607
State Location: NY
State of Inc.: NY
- Nasdaq:REGN
Form: 8-K
Filing Date: 17 Jun 2026Report Date: 12 Jun 2026
Accepted: 17 Jun 2026 02:05 p.m.
Accession Number: 0001104659-26-075127
File Number: 000-19034
Film Number: 261098352
Items: 5.07
Documents
Primary Document: FORM 8-K
Accepted: 17 Jun 2026 02:05 p.m.
0001104659-26-075127-index-headers.html
Last Modified: 17 Jun 2026 02:05 p.m.
0001104659-26-075127-index.html
Last Modified: 17 Jun 2026 02:05 p.m.
0001104659-26-075127.txt
Last Modified: 17 Jun 2026 02:05 p.m.
0001104659-26-075127-xbrl.zip
Last Modified: 17 Jun 2026 02:05 p.m.
FilingSummary.xml
Last Modified: 17 Jun 2026 02:05 p.m.
MetaLinks.json
Last Modified: 17 Jun 2026 02:05 p.m.
R1.htm
Last Modified: 17 Jun 2026 02:05 p.m.
regn-20260612.xsd
Last Modified: 17 Jun 2026 02:05 p.m.
regn-20260612_lab.xml
Last Modified: 17 Jun 2026 02:05 p.m.
regn-20260612_pre.xml
Last Modified: 17 Jun 2026 02:05 p.m.
report.css
Last Modified: 17 Jun 2026 02:05 p.m.
Show.js
Last Modified: 17 Jun 2026 02:05 p.m.
tm2618117d1_8k_htm.xml
Last Modified: 17 Jun 2026 02:05 p.m.